Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Study to Evaluate Imetelstat (GRN163L) in Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) Ended

2024-511348-25-00 Myelodysplastic syndromes (MDS) 10 2015-12-11
A Study of Apalutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants with mHSPC Ended

2023-508607-20-00 Metastatic Hormone-sensitive Prostate Cancer 5 2015-11-27
BEVERLY: A randomized open-label phase 3 trial comparing bevacizumab + erlotinib vs erlotinib alone as first line treatment of patients with… Ended

2024-516843-15-00 Non-squamous Non-small Cell Lung Cancer 5 2015-11-23
Study of two different doses of cabozantinib in progressive, metastatic medullary thyroid cancer Ended

2024-516480-90-00 Metastatic Medullary Thyroid Cancer 6 2015-11-23
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lun… Ended

2023-505981-26-00 Non−Small Cell Lung Cancer 5 2015-11-20
RANDOMIZED STUDY COMPARING SENTINEL NODE POLICY TO CURRENT INITIAL STAGING PROTOCOLS IN EARLY STAGE ENDOMETRIAL CARCINOMAS AT INTERMEDIATE A… Ended

2024-513079-42-00 Intermediate-risk, high risk endometrial cancer 5 2015-11-19
Phase 2 open label randomized study of radiotherapy, concomitant nimotuzumab and vinorelbine and re-irradiation at relapse versus radiothera… Ended

2024-513654-30-00 Diffuse intrinsic pontine glioma 4 2015-11-04
PALLAS - PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy vers… Ended

2024-514841-12-00 To determine whether the addition of palbociclib to adj 5 2015-10-27
A Randomized multicenter phase III trial comparing enzalutamide vs. a combination of Ra223 and enzalutamide in asymptomatic or mildly sympto… Ended

2023-510453-41-00 Castration resistant prostate cancer patients metastati 5 2015-10-26
A trial to learn how well osimertinib (AZD9291) works to prevent cancer from coming back after surgery and how safe it is compared to the pl… Ended

2023-506524-82-00 Stage IB-IIIA non-small cell lung carcinoma, with a cen 5 2015-10-21
eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients Ended

2024-513454-29-00 Non-Small Cell Lung Cancer (NSCLC) 5 2015-10-15
A Randomized, Multicenter, Open-Label, Non-Inferiority, Phase 3 Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects with High R… Ended

2023-509347-27-00 High Risk Chronic Lymphocytic Leukaemia 5 2015-09-30
An Open-label, Phase 2 Study of ACP-196 in Subjects with Waldenström Macroglobulinemia1 Ended

2023-509356-34-00 Waldenström Macroglobulinemia 4 2015-09-28
Adaptive phase II randomized non-comparative trial of nivolumab after induction treatment in triple-negative breast cancer (TNBC) patients: … Ended

2025-520487-18-00 Triple negative breast cancer (TNBC) patients with meta 4 2015-09-08
An international study to evaluate the safety and effectiveness of enzalutamide plus leuprolide, enzalutamide alone, and leuprolide alone in… Ended

2024-513521-23-00 Prostate Cancer 5 2015-08-19
An open label, multi-center, Phase IV rollover protocol to evaluate long term safety data Ended

2024-515283-31-00 This study is designed to accept patients with varied d 6 2015-07-30
A Phase I study of IDH305 in patients with advanced malignancies that harbor IDH1R132 mutations Ended

2023-507421-41-00 Advanced malignancies that harbor IDH1R132 mutations 1 2015-07-20
Adjuvant immunotherapy with anti-PD-1 monoclonal antibody Pembrolizumab (MK-3475) versus placebo after complete resection of high-risk Stage… Ended

2023-509136-25-00 Stage III melanoma (AJCC R0) with histologically confir 5 2015-07-16
Phase III trial of laryngeal preservation comparating chemotherapy followed by radiotherapy to chemotherapy administrated during radiotherap… Ended

2024-513976-16-00 squamous cell carcinomas of the larynx or hypopharynx l 5 2015-06-26
Phase I/II study to evaluate the efficacy and safety of PAZOPANIB in combination with TEMOZOLOMIDE as maintenance therapy in Glioblastoma pa… Ended

2024-510960-22-00 gliobastoma 9 2015-06-25
Study to evaluate the effectiveness of a combination of 3 treatments, followed by transplantation of their own blood cell progenitor cells f… Ended

2024-516908-42-00 Smoldering multiple myeloma with high risk of progressi 4 2015-06-15
A clinical study to evaluate the efficacy of ceritinib in combination with nivolumab in patients with ALK positive lung cancer Ended

2024-510824-38-00 Non-small cell lung cancer 3 2015-05-27
A trial to see the effects of increased doses of ACP-196 (the test drug) in subjects with Leukemia Ended

2023-509346-35-00 Richter's Syndrome 9 2015-05-26
A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination with Chlorambucil, ACP 196 in Combination with Obi… Ended

2023-509348-84-00 Chronic Lymphocytic Leukemia 5 2015-04-27